OTCBB:INBP
Integrated BioPharma, Inc. Stock News
$0.240
+0 (+0%)
At Close: Jun 25, 2024
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024
04:30pm, Friday, 10'th May 2024
HILLSIDE, NJ / ACCESSWIRE / May 10, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2024. Revenue for each of the
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023
04:25pm, Monday, 12'th Feb 2024
HILLSIDE, NJ / ACCESSWIRE / February 12, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2023. Revenue for the
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023
02:15pm, Thursday, 09'th Nov 2023
HILLSIDE, NJ / ACCESSWIRE / November 9, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2023. Revenue for the
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023
05:15pm, Friday, 15'th Sep 2023
HILLSIDE, NJ / ACCESSWIRE / September 15, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2023. Re
Integrated BioPharma GAAP EPS of $0.03, revenue of $14.6M
07:57am, Friday, 11'th Feb 2022 Seeking Alpha
Integrated BioPharma press release (INBP): FQ2 GAAP EPS of $0.03.Revenue of $14.6M (+2.4% Y/Y).
OTC Markets Group Welcomes Integrated BioPharma, Inc. to OTCQX
07:00am, Friday, 22'nd Jan 2021
NEW YORK, Jan. 22, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced Integrated BioPharma, Inc. (OTCQX: IN
Integrated BioPharma: Strong Growth For Less Than A 5 P/E
02:47pm, Thursday, 19'th Nov 2020
The company's quarterly results saw revenue increase 33% and earnings increase 233% to $0.04 per share. With a current share price of about $0.60, the stock is trading for under 4x trailing earnings.
